Zhejiang Medicine Co Ltd (600216) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Zhejiang Medicine Co Ltd (Zhejiang Medicine) develops, manufactures, and commercializes biological drugs, pharmaceutical intermediates, and bio-pesticides. The company's product portfolio consists of animal nutrition, active pharmaceutical ingredients (APls) and intermediates; antibiotics and human nutrition products including vitamin E, natural vitamin E, vitamin A, vitamin D3 and other pharmaceutical preparations. The company provides its products in large and small volume injections, freeze dried powder injections, tablets, hard and soft capsules, pills and oral solutions. It has two research and development centers, namely, Shaoxing Research Institute of Pharmaceutical Industry and Shanghai Health Creation Biological Drug Research and Development Center. Zhejiang Medicine is headquartered in Shaoxing, Zhejiang, China.Zhejiang Medicine Co Ltd Key Recent Developments
- Jun 28, 2022: The company's subordinate party branch brand creation phased results inspection ended successfully
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Hubei Guangji Pharmaceutical Co Ltd
- Tasly Pharmaceutical Group Co Ltd
- Shandong Xinhua Pharmaceutical Co Ltd
- Skystar Bio-Pharmaceutical Co
- North China Pharmaceutical Co Ltd
- China Resources Jiangzhong Pharmaceutical Group Co Ltd
- Zhejiang NHU Co Ltd
- Yifan Pharmaceutical Co Ltd
- Sinopharm Group Co Ltd
- China Meheco Group Co Ltd
- Tasly Pharmaceutical Group Co Ltd
- China Resources Jiangzhong Pharmaceutical Group Co Ltd
- Shandong Xinhua Pharmaceutical Co Ltd
- China Meheco Group Co Ltd
- Hubei Guangji Pharmaceutical Co Ltd
- Skystar Bio-Pharmaceutical Co
- North China Pharmaceutical Co Ltd
- Yifan Pharmaceutical Co Ltd
- Sinopharm Group Co Ltd
- Zhejiang NHU Co Ltd